Kubister pharmaceutical injection with daptomycin to restore imports

Medical Network September 27th News On September 26, the State Drug Administration issued the "Announcement on Restoring the Importation of Daptomycin for Injection of Kubite Pharmaceutical Co., Ltd.".

Original national food drug On August 17, 2015, the General Administration of Supervision and Administration issued the Notice on Stopping the Import of Three Varieties, such as Aihongtongtong (No. 53 of 2015), and decided to stop the Cubic Pharmaceutical Co., Ltd. (English name: Cubist Pharmaceuticals) , Inc.) The import of Daptomycin for Injection (English name: Daptomycin for Injection). After the rectification, Kubister Pharmaceutical Co., Ltd. proposed to resume import and accepted the production of the former State Food and Drug Administration. Re-examination of the plant (OSO Biopharmaceuticals Manufacturing, LLC.). Based on the results of the re-inspection and enterprise The further rectification report, the State Drug Administration considered that its rectification meets the relevant requirements, decided to restore Kubite Pharmaceutical Co., Ltd. (in 2016, the company's English name was changed to: Cubist Pharmaceuticals, LLC.) Imported daptomycin for injection, All port food and drug administrations are required to resume the import customs clearance of injectable daptomycin from Kubite Pharmaceutical Co., Ltd. from the date of publication.